References
- Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002 Jan; 13(Suppl 1): S37-40. PubMed | Google Scholar
- Foley RN, Parfrey P, Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis.1998 Nov; 32(5 Suppl 3): S112-9. Google Scholar
- Weiner DE, Tighiouart H, Amin MG, Stark PC et al. Chronic kidney disease as a risk factor for cardiovascular disease and all cause mortality: a pooled analysis of community based studies. J Am Soc Nephrol. 2004 May; 15(5): 1307-15. PubMed | Google Scholar
- Eghan BA, Amoako-Atta K, Kankam CA, Nsiah-Asare A. Survival pattern of hemodialysis patients in Kumasi, Ghana: a summary of forty patients initiated on hemodialysis at a new hemodialysis unit. Hemodial Int. 2009 Oct; 13(4): 467-471. PubMed | Google Scholar
- Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and non-traditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol 2005 Feb; 16(2): 529-538. Google Scholar
- Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE et al. Pre-dialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kid Dis.1999 Mar; 33(3):507-17. Google Scholar
- Kasiske BL. Hyperlipidemia in patients with chronic renal disease. Am J Kid Dis. 1998 Nov; 32(Suppl 3): S142-56. PubMed | Google Scholar
- Thomas R, Kanso A, Sedor JR. Chronic Kidney Disease and its complications. Prim Care. 2008 Jun; 35(2): 329-44. PubMed | Google Scholar
- Parfrey PS (editor). Cardiac disease in chronic uraemia: uraemia related risk factors. Semin Dial.1999;20(14):997-1008. Google Scholar
- Shlipak MG, Fried LF, Cushman M, Manolio TA et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA. 2005 Apr 13; 293(14): 1737-1745. PubMed | Google Scholar
- Agarwal R, Light RP. Determinants and Prognostic Significance of Electrocardiographic Left Ventricular Hypertrophy Criteria in Chronic Kidney Disease. Clin J Am Soc Nephrol. 2011 Mar; 6(3): 528-36. PubMed | Google Scholar
- Stewart GA, Gansvoort RT, Mark PB, Rooney E et al. Electrocardiographic
abnormalities and uraemic cardiomyopathy. Kidney Int. 2005 Jan; 67(1): 217-26. Google
Scholar
- Chijioke A, Makusidi AM, Kolo PM. Electrocardiographic
abnormalities among dialysis naïve chronic kidney patients in Ilorin, Nigeria.
Ann Afr Med. 2012 Jan-Mar; 11(1): 21-6. PubMed | Google
Scholar
- Nwankwo EA, Ummate I, Wudiri W. Prevalence of electrocardiographic
left ventricular hypertrophy among incident dialysis patients in Maiduguiri,
Nigeria. Res J Medicine and Med Sci. 2007; 2(1): 1-4. Google
Scholar
- Foley RN, Parfrey PS, Harnett JD, Kent GM et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int.1995 Jan; 47(1): 186-92. PubMed | Google Scholar
- Ulasi II, Arodiwe EB, Ijoma CK. Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation. Ethn Dis. 2006 Autumn; 16 (4): 859-64. PubMed | Google Scholar
- McQuarie EP, Patel RK, Mark PB, Delles C et al. Association between proteinuria and left ventricular mass index: a cardiac MRI study in patients with chronic kidney disease. Nephrol Dial Transp. 2011 Mar; 26(3): 933-938. Google Scholar
- Sokolow M, Lyon T. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949; 37(2): 161-186. PubMed | Google Scholar
- Okin PM, Devereux RB, Jern S, Kjeldsen SE et al, LIFE Study Investigators. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA. 2004 Nov; 292(19): 2343-9. PubMed | Google Scholar
- Mathew J, Sleight P, Lonn E, Johnstone D et al. Reduction
of cardio- vascular risk by regression of electrocardiographic markers of left
ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril.
Circulation. 2001 Oct 2; 104(14): 1615-21. PubMed | Google
Scholar
- Ulasi II, Ijoma CK. The Enormity of Chronic Kidney Disease in Nigeria: the Situation in a Teaching Hospital in South-East Nigeria. J Trop Med. 2010 Jun; 2010(2010): 501957. PubMed | Google Scholar
- Amoako YA, Laryea DO, Bedu-Addo G, Andoh H, Awuku YA. Clinical and demographic characteristics of chronic kidney disease patients in a tertiary facility in Ghana. The Pan African Medical Journal. 2014; 18:274. PubMed | Google Scholar
- Cappuccio
FP, Micah FB, Emmett L, Kerry SM et al. Prevalence, detection, management,
and control of hypertension in Ashanti, West Africa. Hypertension. 2004 May;
43(5): 1017-22. PubMed | Google
Scholar
- Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996 Mar; 27(3): 347-54. PubMed | Google Scholar
- Chen SC, Chang J, Liu WC, Tsai Y-C et al. Stepwise Increases in Left Ventricular Mass Index and Decreases in Left Ventricular Ejection Fraction Correspond with the Stages of Chronic Kidney Disease in Diabetes Patients. Exp Diabetes Res. 2012; 2012(2012): 789325. PubMed | Google Scholar
- Bregman R, Lemos C, Filho RP, Abensur H et al. Left ventricular
hypertrophy in patients with chronic kidney disease under conservative treatment.
J Bras Nefrol. 2010; 32(1): 83-88. Google
Scholar
- Ravera M, Re M, Deferrari L, Vettoretti S, Deferrari G. Importance of blood pressure control in chronic kidney disease. J Am Soc Nephrol. 2006 Apr; 17(4 Suppl 2): S98-103. PubMed | Google Scholar
- Campese VM, Mitra N, Sandee D. Hypertension in renal
parenchymal disease: why is it so resistant to treatment? Kidney Int. 2006
Mar; 69(6): 967-73. PubMed | Google
Scholar
- Devereux RB, Dahlof B, Gerdts E, Boman K et al. Regression
of hypertensive left ventricular hypertrophy by Losartan compared with Atenolol:
the Losartan intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Circulation. 2004 Sep 14; 110(1): 1456-62. PubMed | Google
Scholar
- Klingbell AU, Schneider M, Martus P, Messerli FH, Schmieder
RE. Meta-analysis of effects of treatment on left ventricular mass in essential
hypertension. Am J Med. 2003 Jul; 115(1): 41-6. Google
Scholar
- Franklin SS, Khan SA, Whong ND, Larson MG, Levy D. Is
pulse pressure useful in predicting risk for coronary heart disease:the Framingham
Heart Study. Circulation. 1999; 100(4): 354-60. PubMed | Google
Scholar
- Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella
G. Left ventricular hypertrophy in non-diabetic predialysis CKD. Am J Kid Dis.
2005; 46(2): 320 -327. PubMed | Google
Scholar
- Lieb W, Mayer B, Stritzke J, Doering A et al. Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: the MONICA/KORA Augsburg Echocardiographic Substudy. Nephrol Dial Transplant. 2006 Oct; 21(10): 2780-7. PubMed | Google Scholar